Role of E2F1 in apoptosis: A case study in feedback loops

Cell Cycle

Volumn 3, Issue 6, 2004, Pages 727-730

  Knezevic, Dejan ^a   Brash, Douglas E ^a,b  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bayesian networks; Boolean networks; c Myc; E2F1; Feedback loop; p53; Systems biology; Transcription factors; Ultraviolet

Indexed keywords

TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; CELL CULTURE; CELL CYCLE; CELL TRANSFORMATION; GENE OVEREXPRESSION; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TISSUE ENGINEERING;

EID: 13244281564     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.3.6.907     Document Type: Review

References (36)

1. Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 1998; 9:585-93.
2. Dyson N. The regulation of E2F by pRb-family proteins. Genes Dev 1998; 12:2245-62.
3. Johnson DJ. The paradox of E2F1: Oncogene and tumor suppressor gene. Mol Care 2000; 27:151-7.
4. Stevens C, La Thangue NB. A new role for E2F-1 in checkpoint control. Cell Cycle 2003; 2:435-7.
5. Carrassa L, Broggini M, Vikhanskaya F, Damia G. Characterization of the 5′flanking region of the human Chk1 gene: identification of E2F1 functional sites. Cell Cycle 2003; 2:604-9.
6. Gomez-Manzano C, Mitlianga P, Fueyo J, Lee HY, Hu M, Spurgers KB, et al. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2. Cancer Res 2001; 61:6693-7.
7. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, et al. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene 2001; 20:6983-93.
8. Vermeulen K, Berneman ZN, Van Bockstaele DR. Cell cycle and apoptosis. Cell Prolif 2003; 36:165-75.
9. Brunner T, Martin SJ. c-Myc: Where death and division collide. Cell Cycle 2004; In press.
10. Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene 2003; 22:9007-21.
11. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, et al. Genomic targets of the human c-Myc protein. Genes Dev 2003; 17:1115-29.
12. Wu X, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. PNAS 1994; 91:3602-6.
13. Qin XQ, Livingston DM, Kaelin WG Jr, Adams PD. Deregulated transcription factor E2 F-1 expression leads to S-phase entry and p53-mediated apoptosis. PNAS 1994; 91:10918-22.
14. Shan B, Lee WH. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 1994; 14:8166-73.
15. Sherr CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev 1998; 12:2984-91.
16. Palmero I, Murga M, Zubiaga A, Serrano M. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2. Oncogene 2002; 21:2939-47.
17. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998; 17:5001-14.
18. ARF-independent mechanisms in human fibroblasts. Oncogene 2003; 22:4993-5005.
19. El-Deiry WS. Regulation of p53 downstream genes. Sem Cancer Biol 1998; 8:345-57.
20. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene 2001; 20:910-20.
21. Irwin M, Marin MC, Phillips AC, Sellan RS, Smith DI, Liu W, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000; 407:645-8.
22. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001; 3:552-8.
23. Wikonkal NM, Remenyik E, Knezevic D, Zhang W, Liu M, Zhao H, et al. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol 2003; 5:655-60.
24. Ma Y, Croxton R, Moorer RL Jr, Cress WD. Identification of novel E2F1-regulated genes by microarray. Arch Biochem Biophys 2002; 399:212-24.
25. Muller H, Bracken AP, Vernell E, Moroni MC, Christians F, Grassili E, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001; 15:267-85.
26. ARF expression. Cell Cycle 2003; 2:127-33.
27. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F1. Cell 1996; 85:537-48.
28. Zhu JW, Field SJ, Gore L, Thompson M, Yang H, Fujiwara Y, et al. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol 2001; 21:8547-64.
29. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG, Livingston DM, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85:549-61.
30. Savageau MA. Comparison of classical and autogenous systems of regulation in inducible operons. Nature 1974; 252:546-9.
31. Becskel A, Serrano L. Engineering stability in gene network by autoregulation. Nature 2000; 405:590-3.
32. Ferrell JE. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and biostability. Curr Opin Chem Biol 2002; 6:140-8.
33. D'haeseleer P, Liang S, Somogyi R. Genetic network inference: from co-expression clustering to reverse engineering. Bioinformatics 2000; 16:707-26.
34. Liang S. Reveal, a general reverse algorithm for inference of genetic network architectures. Pacific Symp Biocomputing 1998; 3:18-29.
35. Oltvai ZN, Barabasi AL. Life's complexity pyramid. Science 2002; 298:763-4.
36. Milo R, Itzkovitz S, Kashtan N, Levitt R, Shen-Orr S, Ayzenshtat I, et al. Superfamilies of evolved and designed networks. Science 2004; 303:1538-42.